Glutamate and Huntington's Disease (Q40086012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

review article

1 reference

title

Glutamate and Huntington's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Glutamate and Huntington's Disease (English)

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

8 August 2023

0 references

P. R. Sanberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119604

8 August 2023

G. A. Johnston

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119604

8 August 2023

language of work or name

English

0 references

publication date

1 October 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

31 October 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6119604

full work available at URL

8 August 2023

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.1981.tb112939.x

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Medical Journal of Australia

8 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

460-465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119604%20AND%20SRC:MED&resulttype=core&format=json

Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: Correlates with a new animal model

27 October 2019

cites work

3

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

8 August 2023

4

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids

8 August 2023

5

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

An animal model for Huntington's disease

8 August 2023

8

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Anterograde and transsynaptic degeneration 'en cascade' in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease

8 August 2023

9

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Inverse relationship between GABA and gamma-hydroxybutyrate levels in striatum of rat injected with kainic acid

8 August 2023

10

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Regional brain levels of gamma-hydroxybutyrate in Huntington's disease

8 August 2023

11

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Angiotensin-converting enzyme in substantia nigra: Reduction of activity in huntington's disease and after intrastriatal kainic acid in rats

8 August 2023

12

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Long-term sequelae of striatal kainate lesion

8 August 2023

13

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection

8 August 2023

14

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

8 August 2023

15

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Locomotor activity, exploration and spatial alternation learning in rats with striatal injections of kainic acid.

8 August 2023

18

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Avoidance, operant and locomotor behavior in rats with neostriatal injections of kainic acid

8 August 2023

19

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid.

8 August 2023

21

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

8 August 2023

22

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainic acid lesions of pigeon paleostriatum: a model for study of movement disorders

8 August 2023

23

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Abnormal locomotion in rats after bilateral intrastriatal injection of kainic acid

8 August 2023

24

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington's disease

8 August 2023

25

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

8 August 2023

Huntington's disease.

26

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease

8 August 2023

29

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat

8 August 2023

31

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Body weight, feeding, and drinking behaviors in rats with kainic acid-induced lesions of striatal neurons—With a note on body weight symptomatology in Huntington's disease

8 August 2023

34

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainic Acid Lesions of the Striatum Dissociate Amphetamine and Apomorphine Stereotypy: Similarities to Huntingdon's Chorea

8 August 2023

35

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Sedative Effects of Apomorphine in an Animal Model of Huntington's Disease

8 August 2023

36

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum

8 August 2023

37

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

The effect of d-amphetamine on choreiform movement disorders

8 August 2023

38

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor

8 August 2023

40

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Modification of Choreiform Activity by Haloperidol

8 August 2023

41

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

A Double Blind Trial of Lithium Carbonate and Haloperidol in Huntington's Chorea

8 August 2023

42

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Central cholinergic-anticholinergic antagonism in Huntington's chorea

8 August 2023

43

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis

8 August 2023

44

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Effect of imipramine (Tofranil) on depression and hyperkinesia in Huntington's disease

8 August 2023

45

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Strain differences and kainic acid neurotoxicity

8 August 2023

46

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Susceptibility of rat neostriatum to damage by kainic acid: age dependence

8 August 2023

47

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation

8 August 2023

48

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Inhibitors of GABA metabolism: Implications for Huntington's disease

8 August 2023

49

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Pharmacological augmentation of acetylcholine levels in kainate-lesioned rat striatum

8 August 2023

50

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Glutamate release in vitro from corticostriatal terminals

8 August 2023

51

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Influence of cortico-striatal afferents on striatal kainic acid neurotoxicity

8 August 2023

52

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract

8 August 2023

53

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

alpha-Aminoadipate blocks the neurotoxic action of N-methyl aspartate

8 August 2023

55

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainate neurotoxicity and glutamate inactivation

8 August 2023

57

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Glutamate neurotoxicity and Huntington's chorea

8 August 2023

58

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Some factors influencing the neurotoxicity of intrastriatal injections of kainic acid

8 August 2023

60

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum

8 August 2023

61

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Morphine, naloxone and kainic acid neurotoxicity

8 August 2023

62

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Ethanol, baclofen, and kainic acid neurotoxicity

8 August 2023

63

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Neurochemical findings in Huntington's chorea

8 August 2023

65

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Biochemical Mechanisms and Management of Choreiform Movement Disorders

8 August 2023

66

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Stimulatory effect of L-glutamate and related amino acids on [3H]dopamine release from rat striatum: an in vitro model for glutamate actions

8 August 2023

67

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue

8 August 2023

68

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP

8 August 2023

69

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Effects of intraventricular glutamic acid on the acquisition, performance, and extinction of an operant response, and on general activity

8 August 2023

70

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Reduction of cerebrospinal fluid glutamic acid in huntington's chorea and in schizophrenic patients

8 August 2023

72

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

L-Glutamate toxicity in Huntington's disease fibroblasts

8 August 2023

73

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Loss of glutamine synthetase activity in the brain in Huntington's disease

8 August 2023

74

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Post-mortem findings do not suggest a brain glutamine deficiency in Huntington's disease

8 August 2023

75

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Glutamine, glutamine synthetase and Huntington's disease

8 August 2023

76

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Amino acids in rat neostriatum: Alteration by kainic acid lesion

8 August 2023

77

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Morphometric studies of the neuropathological changes in choreatic diseases

8 August 2023

78

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainic acid affects both plexiform layers of chicken retina

8 August 2023

80

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Kainic acid binding in human caudate nucleus: Effect of Huntington's disease

8 August 2023

82

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Methyltetrahydrofolate is a potent and selective agonist for kainic acid receptors

8 August 2023

83

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Long term treatment of Huntington disease with L-glutamate and pyridoxine

8 August 2023

84

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Possible pathogenesis of Huntington's chorea and a new approach to treatment

8 August 2023

85

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

Antagonism of intrastriatal and intravenous kainic acid by 1-nuciferine: comparison with various anticonvulsants and GABAmimetics.

8 August 2023

86

1 reference

https://api.crossref.org/works/10.5694/J.1326-5377.1981.TB112939.X

8 August 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6119604

8 August 2023

1 reference